Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)	Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, diarrheal disease	Recruiting	Phase 2	2025-06-27		NCT05663775

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AHS Cancer Control Alberta	37

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cross Cancer Institute	Edmonton	Canada	6

Clinical trials